Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

Our laboratory is interested in the use of mouse models of prostate cancer to explore the pathogenesis of prostate cancer and its response to treatment. We have used the SV-40 based TRAMP model of ...

Selecting an appropriate mouse model is one of the most important decisions a pre-clinical researcher can make. Which is best suited for immuno-oncology? Cancer research and drug discovery has ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...

We employ cutting edge patient-derived organoid and mouse models of colorectal cancer, transcriptomic, epigenomic and single cell approaches, and mechanistic studies to: (1) elucidate how tumor ...

Oxford Drug Design has reported positive results from an in vivo colorectal cancer model study on mice, which, it said, ...

Fiber digestion produces short-chain fatty acids like propionate and butyrate, which directly alter gene expression with anti ...

“The study looks at an important area of colorectal cancer biology using rigorous mouse models. And it's attempting to address two pathways by which colon cancer initiates,” said Nilay Sethi, a cancer ...

the research team developed and tested a drug strategy using those amino acids to treat colorectal cancer in cell lines and in a mouse model of cancer. Epigenetics refers to chemical alterations ...

An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...